Towards Healthcare
Digital PCR (dPCR) and Real-time PCR (qPCR) Market to Hit USD 21.87 Bn by 2034

Digital PCR (dPCR) and Real-time PCR (qPCR) Market Outlook 2025 North America Leads, Asia Pacific Set for Fastest CAGR Growth

Market insights predict, the digital PCR (dPCR) and real-time PCR (qPCR) industry is expected to grow from USD 10.15 billion in 2024 to USD 21.87 billion by 2034, driven by a CAGR of 7.97%. The digital PCR (dPCR) and real-time PCR (qPCR) market is growing due to rising demand for gene sequencing and the development of gene therapies. North America is leading due to a strong presence of the biotechnology industry. 

  • Insight Code: 5984
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: August 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

FAQ's

The digital PCR (dPCR) and real-time PCR (qPCR) Market holds a valuation of USD 10.96 billion in 2025 and will expand to USD 21.87 billion by 2034, achieving a CAGR of 7.97% between 2024 and 2034.

North America is currently leading the digital PCR (dPCR) and real-time PCR (qPCR) market due to the development in multi-omics and demand for gene therapies.

Some key players include Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., Agilent Technologies, Inc., Fluidigm Corporation, Stilla Technologies, etc.

Key trends include rising focus on multi-omics and single-cell sequencing.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.